一个神圣的马乔林在一个患者之前的背部
Joseph J Santora1, Jae-Chiang Wong2, Tyler Faimon3
1Department of Medicine, AtlantiCare Regional Medical Center, Atlantic City, NJ.
Advances in skin & wound care
|February 10, 2026
概括
一种罕见的圣骨Marjolin,一种类型的皮肤癌,从腰部部发展. 这一案例凸显了早期诊断Marjolin的必要性,即使是异常呈现,以改善患者的治疗结果.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 马乔林是恶性皮肤生长,通常与慢性伤口有关,特别是烧伤痕.
- 虽然通常会在多年内出现,但亚急性表现不太常见.
- 这种病例涉及一个神圣的Marjolin,在下背之后发展.
研究的目的:
- 报告一个罕见的圣骨Marjolin的病例.
- 强调在非经典的伤口呈现中考虑马乔林的重要性.
- 强调早期怀疑和诊断的必要性.
主要方法:
- 案例报告的呈现方式.
- 对患者病史的审查,重点关注慢性伤口和.
- 皮肤恶性瘤的临床和病理检查.
主要成果:
- 在一个患有下背的病史的病人身上发现了一种神圣的Marjolin.
- 呈现是亚急性,不同于典型的慢性伤口发展.
- 通过临床和病理学评估确认了诊断.
结论:
- 神圣马乔林可以从亚急性疾病如疹中产生,而不仅仅是慢性伤口.
- 早期怀疑和诊断至关重要,特别是在缺乏经典Marjolin风险因素的患者中.
- 这一案例扩大了对马乔林的病因和表现的理解.
相关概念视频
Peptic Ulcer Disease II: Pathophysiology
2.2K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.2K
Peptic Ulcer Disease I: Introduction
891
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
891
Peptic Ulcer Disease IV: Management
538
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
538
Drugs for Treatment of Ulcerative Colitis in IBD
535
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
535
Inflammatory Bowel Disease I: Ulcerative Colitis
1.1K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.1K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.3K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.3K


